Dr. Kyoungho Suk is currently a professor of Department of Pharmacology, Kyungpook National University (KNU) School of Medicine (Daegu, Korea). He obtained his Ph.D. in Immunology at University of California at Davis in 1994, and M.S. degree in Immunology at Cornell University in 1991. He graduated from KNU with the genetic engineering major in 1989. Prof. Suk received his postdoctoral training in the division of Rheumatology, Yale University School of Medicine, and he has been a visiting professor at Harvard Medical School between 2008 and 2009, during which he participated in large-scale experiments and systems biology approaches toward understanding of disease networks and pathways. Prof. Suk is the author of more than 200 papers published in peer-reviewed journals (h-index 41, total citations 5,937), and holds patents on various therapeutic targets and lead compounds that could be used for the diagnosis or therapy of neuroinflammatory and neurodegenerative diseases. Prof. Suk is currently acting as an associate editor of J Neurosci Res, and editorial board of J Neuroinflammation, Exp Neurobiol, Medicine, Mol Cells, Biochem Pharmacol, etc. Prof. Suk’s lab is interested in the proteins secreted from glia. A long-term goal of the lab is to identify and functionally characterize glial secretory proteins with respect to brain health and disease. Their findings so far based on in vitro and in vivo experiments as well as the analyses of clinical samples led them to propose that these glial proteins might be valuable theragnostic biomarkers and drug targets for the CNS injuries and disorders such as Alzheimer's disease. Omics approach and large-scale experiments are being employed to better understand a big picture of neuroinflammation and to uncover new drug targets.